chr7-157187002-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014671.3(UBE3C):āc.1312A>Gā(p.Met438Val) variant causes a missense change. The variant allele was found at a frequency of 0.000417 in 1,607,266 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00022 ( 0 hom., cov: 32)
Exomes š: 0.00044 ( 0 hom. )
Consequence
UBE3C
NM_014671.3 missense
NM_014671.3 missense
Scores
1
18
Clinical Significance
Conservation
PhyloP100: 3.95
Genes affected
UBE3C (HGNC:16803): (ubiquitin protein ligase E3C) Enables ubiquitin protein ligase activity. Involved in protein polyubiquitination. Predicted to be located in nucleus. Predicted to be part of proteasome complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.024837822).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UBE3C | NM_014671.3 | c.1312A>G | p.Met438Val | missense_variant | 10/23 | ENST00000348165.10 | NP_055486.2 | |
UBE3C | XM_047421072.1 | c.1249A>G | p.Met417Val | missense_variant | 10/23 | XP_047277028.1 | ||
UBE3C | XM_005249564.5 | c.1237A>G | p.Met413Val | missense_variant | 9/22 | XP_005249621.1 | ||
UBE3C | XM_047421073.1 | c.1312A>G | p.Met438Val | missense_variant | 10/16 | XP_047277029.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UBE3C | ENST00000348165.10 | c.1312A>G | p.Met438Val | missense_variant | 10/23 | 1 | NM_014671.3 | ENSP00000309198 | P1 | |
UBE3C | ENST00000389103.4 | c.1183A>G | p.Met395Val | missense_variant | 8/9 | 5 | ENSP00000373755 |
Frequencies
GnomAD3 genomes AF: 0.000223 AC: 34AN: 152154Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
34
AN:
152154
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000351 AC: 83AN: 236602Hom.: 0 AF XY: 0.000392 AC XY: 50AN XY: 127602
GnomAD3 exomes
AF:
AC:
83
AN:
236602
Hom.:
AF XY:
AC XY:
50
AN XY:
127602
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000438 AC: 637AN: 1454992Hom.: 0 Cov.: 30 AF XY: 0.000394 AC XY: 285AN XY: 723116
GnomAD4 exome
AF:
AC:
637
AN:
1454992
Hom.:
Cov.:
30
AF XY:
AC XY:
285
AN XY:
723116
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000223 AC: 34AN: 152274Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74472
GnomAD4 genome
AF:
AC:
34
AN:
152274
Hom.:
Cov.:
32
AF XY:
AC XY:
16
AN XY:
74472
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
3
ALSPAC
AF:
AC:
2
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
3
ExAC
AF:
AC:
52
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 13, 2021 | The c.1312A>G (p.M438V) alteration is located in exon 10 (coding exon 10) of the UBE3C gene. This alteration results from a A to G substitution at nucleotide position 1312, causing the methionine (M) at amino acid position 438 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;.
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;.
MutationTaster
Benign
D;D
PrimateAI
Benign
T
PROVEAN
Benign
N;.;N
REVEL
Benign
Sift
Benign
T;.;T
Sift4G
Benign
T;T;T
Polyphen
B;B;B
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at